← peptides typeshit

Retatrutide beat Ozempic on A1c and weight in Lilly's 80-week diabetes study

Lilly says top-dose users lost 20.9% of body weight versus 9.4% on Ozempic, counting only people who stayed on treatment.

Read at STAT

Recap by typeshit. Full story at STAT.